According to Glenmark, the nitric oxide nasal spray (NONS) will be sold under the brand FabiSpray in India for the treatment of adult patients with Covid-19 who have high risk of progression of ...

Ryaltris, which was developed by Glenmark, is a novel, fixed-dose combination nasal spray of an anti-histamine (olopatadine hydrochloride) and a steroid (mometasone furoate). Each unit of the ...

Glenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray for the treatment of seasonal allergic rhinitis.

approval for nasal spray fixed dose prescription drug for seasonal allergic rhinitis Ryaltris. According to Glenmark, the drug is for rhinitis in adults and paediatric patients 12 years of age and ...

The first recall affects 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray. Glenmark ...

Glenmark Pharmaceuticals has witnessed a significant ... a stock broking and investment banking firm. Ryaltris is a nasal spray used for the treatment of symptoms associated with seasonal allergic ...